Patent intelligence · US
US 10662183
Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same
Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of…
Patent details — US 10662183
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 26, 2020
- Expiration
- May 21, 2040
- Claims
- 12
- CPC classes
- A61P, A61P35/00
Quick answer
US 10662183 (Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same) is held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN. Status: granted. Granted May 26, 2020. Expires May 21, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 12
- CPC classes
- A61P, A61P35/00
More from THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 10662183?
US 10662183 (Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same) is held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN. Status: granted. Granted May 26, 2020. Expires May 21, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10662183?
THE REGENTS OF THE UNIVERSITY OF MICHIGAN is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 10662183 expire?
Our index shows an expiration date of May 21, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.